Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
<p>We describe a 79-year-old man with spondylodiscitis and unknown pathogen, treated with cefazolin and rifampicin. He developed a massive digestive hemorrhage. Prothrombin time was prolonged with severe vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur during cefazolin...
Main Authors: | I. Kouki, C. Montagner, W. Mauhin, J. London, T. Lazard, S. Grimbert, V. Zeller, O. Lidove |
---|---|
Format: | Article |
Language: | English |
Published: |
Copernicus Publications
2021-04-01
|
Series: | Journal of Bone and Joint Infection |
Online Access: | https://jbji.copernicus.org/articles/6/131/2021/jbji-6-131-2021.pdf |
Similar Items
-
Deranged Coagulation Profile Secondary to Cefazolin Use: Case Report
by: Jinghao Nicholas Ngiam, et al.
Published: (2021-03-01) -
Is it just a cefazolin issue?
by: Tomonori Takazawa, et al.
Published: (2019-09-01) -
Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
by: Wladimir Mauhin, et al.
Published: (2019-01-01) -
Pharmacokinetics of cefazolin for prophylactic administration to dogs
by: González-Cintrón, Omar J.
Published: (2017) -
A case report: anaphylaxis to cefazolin during renal transplant surgery
by: Kaveh Hemati, et al.
Published: (2021-05-01)